SUSAN PARKS: Open Payments
NPI 1841683331 · LEWES, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$789 in 39 payments from 13 companies in 2025. Trend: 2023 $345 · 2024 $962 · 2025 $789
Food & beverage: $789
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 10 | $142 |
| Novo Nordisk Inc | 8 | $135 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $114 |
| Lilly USA, LLC | 4 | $77 |
| Exact Sciences Corporation | 3 | $73 |
| Amgen Inc. | 4 | $71 |
| Merck Sharp & Dohme LLC | 2 | $49 |
| AstraZeneca Pharmaceuticals LP | 2 | $33 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $22 |
| Abbott Laboratories | 1 | $21 |
Products named: ELIQUIS, MOUNJARO, The Cologuard Plus Collection Kit, NURTEC ODT, OTEZLA, Ozempic, AIRSUPRA, KRYSTEXXA.
Industry payments across DE — which companies pay providers there.
